MMSI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Merit Medical Systems Inc (MMSI) is not a strong buy for a beginner, long-term investor at this moment. While the company has shown solid financial growth in its latest quarter, the lack of recent positive trading signals, neutral sentiment from hedge funds and insiders, and a mixed analyst outlook with lowered price targets suggest limited upside potential in the near term. Additionally, technical indicators do not provide a clear bullish signal, and options data reflects a bearish sentiment. Considering the investor's preference for long-term growth, it may be better to wait for a more favorable entry point or clearer catalysts for growth.
The MACD is positive at 0.267, indicating a mild bullish trend, but it is contracting. RSI is neutral at 43.505, suggesting no strong momentum. Moving averages are converging, showing indecision in price direction. Key support is at 68.094, and resistance is at 71.384. The stock is trading near its support level, but there is no clear breakout signal.
The company reported strong financial growth in Q4 2025, with revenue up 10.92% YoY, net income up 35.99% YoY, and EPS up 36.96% YoY. Gross margin also improved by 1.81%.
No recent news or catalysts have been identified to drive the stock higher in the short term.
In Q4 2025, Merit Medical reported strong financial results: Revenue increased to $393.9M (+10.92% YoY), Net Income rose to $38M (+35.99% YoY), EPS grew to $0.63 (+36.96% YoY), and Gross Margin improved to 49.59% (+1.81% YoY).
Analysts maintain a generally positive outlook with Buy and Outperform ratings, but several firms have lowered price targets recently. The average price target has been reduced, reflecting concerns about short-term impacts from acquisitions and fiscal guidance uncertainty.
